Dow Up 0.11% Nasdaq Up 0.50%

Advaxis, Inc. (ADXS)

-NasdaqCM
3.88 Aug 29, 3:59PM EDT
Prev Close:3.88
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:13.50
Beta:1.16
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:2.46 - 11.70
Volume:0
Avg Vol (3m):241,135
Market Cap:74.78M
P/E (ttm):N/A
EPS (ttm):-2.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXS 0.00%74.78M
BVTIN/A
DNDN211.38M
VICL109.87M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):74.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-14) :-1.16
Quarterly EPS Est (Jul-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback